CeriBell reported first-quarter revenue growth of 29% and raised its full-year outlook, citing increased usage of its seizure monitoring system. Management also highlighted the company's strongest quarter of net new hospital additions since becoming public. The update points to improving demand and expanding adoption, which should be supportive for the stock.
CeriBell reported first-quarter revenue growth of 29% and raised its full-year outlook, citing increased usage of its seizure monitoring system. Management also highlighted the company's strongest quarter of net new hospital additions since becoming public. The update points to improving demand and expanding adoption, which should be supportive for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.68
Ticker Sentiment
